A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
PHASE2
The primary objective is to assess the activity and efficacy of pembrolizum...
Status
Active Not Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy Delivery
EARLY_PHASE1
The purpose of this study is to characterize the reduction in PSMA-avid tum...
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
PHASE2
This is a single-arm, open-label phase 2 study to evaluate the role of pacr...